This means the FDA recognizes that AOD 9604 is safe under conditions of intended use
These include a relative or absolute increase in glucagon secretion from alpha cells of the pancreas, elevated serum free fatty-acid concentrations, an impaired incretin effect (e.g., decreased secretion of glucagon-like peptide-1 [GLP-1]), enhanced renal reabsorption of glucose, and dysregulation of appetite control via decreased neurotransmitter response in the brain
Read much more about GlyNAC and sleep right here: GlyNAC and sleep improvement In a clinical study on older adults, GlyNAC supplementation over 24 weeks was shown to restore glutathione levels, reduce oxidative stress, and improve mitochondrial function
There has been a marked increase in the use of these medications since they were first approved for weight loss in 2014, particularly following the approval of Wegovy in 2021 and Zepbound in 2022
Barouch LA, Berkowitz DE, Harrison RW, ODonnell CP, Hare JM
Related Blogs Read more of our latest articles